The ~$19M liability extinguishment significantly strengthens the balance sheet, but the 666,667-share license issuance creates dilution. Monitor the next 10-Q for the full impact on equity and any further details on the REBOOT platform integration.
Price Chart
Executive Summary
DataMeds AI filed an 8-K confirming stockholders' equity exceeds $2.5M, driven by two transactions: (1) a settlement agreement extinguishing ~$19M in liabilities for $450K cash and repurchase of 364,099 shares, and (2) a license agreement with REBOOT Health AI for a care management platform, paid with 666,667 newly issued shares. The liability extinguishment is a material balance-sheet improvement, but the share issuance for the license adds dilution.
Key Facts
- Stockholders' equity confirmed >$2.5M as of October 13, 2026.
- Settlement agreement extinguished ~$19M in liability for a cash payment of $450,000.
- Company repurchased and extinguished 364,099 shares for $350,000 as part of the settlement.
- Entered into a license agreement with REBOOT Health AI, issuing 666,667 shares of common stock.
- Settlement resolved litigation related to a 2023 Membership Interest Purchase Agreement.
Financial Impact
Liability reduced by ~$19M; cash outlay of $450K; 364,099 shares repurchased and cancelled; 666,667 new shares issued for license.
Risk Factors
- Dilution from 666,667 newly issued shares for the license agreement.
- Settlement terms may involve ongoing obligations not fully disclosed.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-046887 |
| Document: 0001493152-26-046887-index-headers.html | 0001493152-26-046887 |
| Document: 0001493152-26-046887-index.html | 0001493152-26-046887 |
| Document: 0001493152-26-046887.txt | 0001493152-26-046887 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $2.15 | awaiting T+20 | — | $2.06 (+4.19%) |
Oct 20, 2026 7d ago | 8-K | $2.75 | awaiting T+20 | — | $2.06 (−25.09%) |
Oct 16, 2026 11d ago | 8-K | $2.67 | awaiting T+20 | — | $2.06 (−22.85%) |
Oct 13, 2026 14d ago | 8-K | $2.85 | awaiting T+20 | — | $2.06 (−27.72%) |
Sep 17, 2026 5w ago | 8-K | $3.76 $2.63 | ▼ −30.05% | ▼ −30.26% | $2.06 (−45.21%) |
Sep 16, 2026 5w ago | 8-K | $4.64 $2.85 | ▼ −38.58% | ▼ −39.78% | $2.06 (−55.60%) |
Aug 18, 2026 10w ago | 8-K | $1.38 $6.07 | ▼ −339.86% | ▼ −341.60% | $2.06 (−49.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers